GlassScriptPhysician profile
Ellina Hattar
NPI 1225483894
$2,177.14
in general payments reported to CMS, 2019-2025
12 companies · $1,279 in 2025
The $1,279 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $184 · 2023: $477 · 2024: $237 · 2025: $1,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909 · Travel and Lodging: $84.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.83 |
| Travel and Lodging | $84.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $523.88 | 2024-2025 | Excelsius Gps, Nvm5, Altera |
| Cerapedics INC. | $370.24 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Stryker Corporation | $314.34 | 2022-2023 | Xia 3, Capri Corpectomy Cage System, Cascadia Interbody System |
| Si-Bone, INC. | $179.21 | 2023 | |
| Vb Spine LLC | $170.01 | 2025 | Cascadia Interbody System |
| Medical Device Business Services, INC. | $124.52 | 2025 | Matrixneuro |
| Ucb, INC. | $118.11 | 2022 | |
| Abbott Laboratories | $115.35 | 2025 | Eterna |
| Carlsmed, INC. | $107.50 | 2025 | Aprevo |
| Alphatec Spine, INC | $104.52 | 2024 | Lif |
| Ebi, LLC | $24.73 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Highridge Medical LLC | $24.73 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellina Hattar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.